Melissa Johnson
SCRI Development Innovations, LLC · Tennessee Oncology · Sarah Cannon
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Melissa Johnson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06773910 · BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)SCRI Development Innovations, LLC · active not recruiting · Limited Stage Small Cell Lung Cancer · study chair
- Ph2NCT05948462 · Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent LorlatinibSCRI Development Innovations, LLC · withdrawn · Lung Cancer, Non-small Cell Lung Cancer · study chair
- Ph1/Ph2NCT05127590 · RBN-2397 in Combination With Pembrolizumab in Patients With SCCLRibon Therapeutics, Inc. · unknown · Advanced Squamous Non-Small Cell Lung Carcinoma · principal investigator
- N/ANCT04976803 · Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-ProteinArtios Pharma Ltd · completed · Solid Tumor, Unspecified, Adult · study chair
- Ph1/Ph2NCT04657068 · A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsArtios Pharma Ltd · recruiting · Advanced Cancer, Metastatic Cancer, Ovarian Cancer · study chair
- Ph1NCT04609579 · Study of SNX281 in Subjects With Advanced Solid Tumors and LymphomaStingthera, Inc. · terminated · Advanced Solid Tumor, Advanced Lymphoma · study chair
- Ph2NCT03977467 · Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 InhibitorSCRI Development Innovations, LLC · completed · Non-Small Cell Lung Cancer, Solid Tumor · study chair
- Ph1NCT03421353 · AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerAstraZeneca · completed · Advanced Solid Tumours · principal investigator
- Ph1NCT02649673 · LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic MalignanciesSCRI Development Innovations, LLC · terminated · Small Cell Lung Cancer, Ovarian Cancer · study chair
- Ph1/Ph2NCT01259089 · Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerNorthwestern University · completed · Adenocarcinoma of the Lung, Non-small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:54 UTC. The ranking covers the 200 most relevant of 1022 PubMed records, and a shared surname and initials can bring in a namesake. All 1022 on PubMed
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.N Engl J Med · 20182,998 citationsRCR 104.0
- Oral apixaban for the treatment of acute venous thromboembolism.N Engl J Med · 20131,781 citationsRCR 65.1
- 1,507 citationsRCR 48.3
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.N Engl J Med · 20221,504 citationsRCR 115.4
- A randomized trial of prenatal versus postnatal repair of myelomeningocele.N Engl J Med · 20111,480 citationsRCR 56.5
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.J Psychopharmacol · 20161,435 citationsRCR 66.0
- Apixaban for extended treatment of venous thromboembolism.N Engl J Med · 20131,027 citationsRCR 37.1
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.JAMA Psychiatry · 2021942 citationsRCR 72.3
- 697 citationsRCR 25.7
- 557 citationsRCR 45.4